ADIPOQ and Other metabolic disease: Indeed, previous reports indicate that adiponectin suppresses inflammatory responses induced by hyperglycemia or TNFα [34], [35], while others have reported that adiponectin promotes inflammatory cytokine production and is associated with a significant increase in cardiovascular disease mortality in patients with metabolic diseases [36]–[39].